Navigation Links
Cell Therapeutics Third Quarter Net Loss Decreases by 68% in 2010 Compared to 2009
Date:10/28/2010

ime 1-800-762-9441 (US Participants)1-480-629-9674 (International)Call-back numbers for post-listening available at 11:30 a.m. Eastern Time:1-800-406-7325 (US Participants)1-303-590-3030  (International)Passcode: 4377948#Live audio webcast at www.celltherapeutics.com will be archived for post-call listening approximately two hours after call ends.

About Cell Therapeutics, Inc.Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the market price of the Company's securities. Specifically, the risks and uncertainties that could affect the development of pixantrone include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general, and with pixantrone in particular, including, without limitation, the potential failure of pixantrone to prove safe and effective for the treatment of relapsed or refractory aggressive NHL and/or other tumors as determined by the FDA and/or the EMEA, that the FDA may not accept the Company's special protocol assessment for pixantrone and/or proposed design for the protocol of the Company's clinical trial and/or may request additional clinical trials, that if the Company conducts an additional clinical trial, it may not demonstrate the safety and effectiveness of pixantrone, that the Company cannot predict or guarantee the pace or geography of enrollment of its clinical trials, that the Company may not initiate a new clinical trial for pixantrone in 2010, that the Company may not submit the MAA
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Veteran Pharmaceutical Executives Form New American Therapeutics, Inc.
2. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
3. Celtic Therapeutics and Resolvyx Pharmaceuticals Announce an Alliance in Ophthalmology
4. Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences
5. Algeta and Lumiphore Announce Global Agreement for the Development of Targeted Alpha-Pharmaceutical Therapeutics
6. BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors
7. Prime Therapeutics Receives 2011 TIPPS Certification
8. Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
9. Talecris Biotherapeutics Receives FDA Approval for Gamunex®-C
10. Prime Therapeutics Announces URAC Accreditation
11. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Actavis, Inc. (NYSE: ACT ) today ... decision of the U.S. Court of Appeals for the Eleventh ... motion to dismiss the Federal Trade Commission,s lawsuit, FTC ... result of a decision by a 5 to 3 vote.  ... adopted the traditional "rule of reason" as the standard.  ...
(Date:6/17/2013)... TEL AVIV, Israel , June 17, 2013 /PRNewswire/ ... 2013, the Board of Governors of the Israel-U.S. Binational ... $10.95 million in funding for fourteen new projects between ... from BIRD , the projects will access private ... to approximately $33 million. The semi-annual meeting was held ...
(Date:6/17/2013)... NEW ORLEANS , June 17, 2013 /PRNewswire/ ... for new technologies that will help improve medication ... process across its health system. ... a combination of hardware and software that helps ... to dispense and administer medications because of simpler, ...
Breaking Medicine Technology:U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 2BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 4Ochsner Health System Improves Safety Through Advanced Medication Management Technology 2Ochsner Health System Improves Safety Through Advanced Medication Management Technology 3Ochsner Health System Improves Safety Through Advanced Medication Management Technology 4Ochsner Health System Improves Safety Through Advanced Medication Management Technology 5
... 23 Neurobiological Technologies, Inc. (Nasdaq: NTII ) ("NTI") ... extraordinary dividend of $0.18 per share of common stock, which ... record as of November 30, 2009. The December 9, 2009 ... pursuant to a plan of complete liquidation and dissolution and ...
... Calif., Nov. 23 Advanced Sterilization Products (ASP), ... today the acquisition by its French affiliate, Apsis ... of innovative disinfection processes and technologies to prevent ... disclosed. , Gloster Europe designs and markets ...
Cached Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2
(Date:6/17/2013)... 2013 Essential tremor (ET) is the ... 10 million people in the United States, and millions ... understanding what causes ET, there are no medications specifically ... Tulips for Tremor© is the International Essential Tremor Foundation’s ... and a cure for this life-altering neurological condition. , ...
(Date:6/17/2013)... initiative helped to boost organ donor registration rates, according ... Journal of Transplantation . The findings suggest that social ... variety of problems related to public health in which ... rates in the United States have remained static while ... year. To provide organs to the more than 100,000 ...
(Date:6/17/2013)... 17, 2013 "Do you think you and ... emailing or using your phone even with a hands free ... is just as dangerous as not using a hands free ... you using Facebook, texting, emailing etc." , It ... their reflexes that distract the brain, according to a study ...
(Date:6/17/2013)... 2013 The personal injury trial ... pleased to announce that firm Partners Stephen J. ... ( http://www.blockotoole.com/Attorneys/David-L-Scher.shtml ) will be appearing on hit ... Sunday, June 23, 2013 at 7a.m. Mr. ... Kevin Burke's "Get Active" show, which highlights professionals ...
(Date:6/17/2013)... Angeles (PRWEB) June 17, 2013 According to ... Sunscreen Questions Answered,” as more and more information surfaces about ... sunscreen should become a vital part of one’s skin ... aging and cancer (Go to goo.gl/qTKZQ). , “I agree ... sunscreen,” says Dr. Simon Ourian, Medical Director of Epione Beverly ...
Breaking Medicine News(10 mins):Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Social media initiative may help increase organ donations 2Health News:Dr. Bonnie Weil Warns Hands Free is Not a Life Saver, It Can Be Just as Much of a Distraction 2Health News:Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital 2Health News:Skin Care – Answers to Your Sunscreen Questions 2
... BOSTON--A duo of drugs, each targeting a prime survival ... potentially more effective than either drug alone for advanced, ... led by Dana-Farber Cancer Institute investigators. The findings ... at the annual meeting of the American Society of ...
... , FRIDAY, JUNE 3 (HealthDay News) -- People ... a heart attack or serious cardiac event, a new ... is that people with mental illness are 14 percent ... condition, researchers found. Those treatments included coronary artery ...
... June 3 (HealthDay News) -- A new strain of ... has been detected in cows, milk in the United ... the department of veterinary medicine at the University of ... new variant, which is genetically different than existing MRSA ...
... tsunami, tornado or flood strike, among the most vulnerable ... Journal of Emergency Management , researchers in New Zealand ... the age-related needs of adults with regards to the ... Tuohy and Christine Stephens of Massey University in Palmerston ...
... School of Medicine (BUSM) researchers have found that Gabapentin, ... neuropathic pain, seizures and biopolar disease in older and ... anorgasmia, or failure to experience orgasm, than previously reported. ... the American Journal of Geriatric Pharmacotherapy . ...
... nationwide hospital databases, University of Cincinnati (UC) emergency medicine ... treatment with the standard therapy for acute ischemic stroke ... Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the ... the journal Stroke . The study estimates between ...
Cached Medicine News:Health News:Combination antibody therapy shows promise in metastatic melanoma 2Health News:Mental Illness Linked to Greater Risk of Death After Heart Attack 2Health News:Helping the aged during natural disasters 2Health News:Use of clot-busting drug for US stroke patients doubled from 2005 to 2009 2
... design and architectural philosophy of the Kenneth ... stylish, targeted to a discerning customer who ... cues directly from Kenneth Cole New York ... Contemporary crystal tones in multi-laminations craft the ...
... Girl Eyewear extends that easy, breezy, beautiful ... styles, featuring an array of stylish colors, ... ,The collection is designed to target the ... who demands affordability,and high-quality, fashionable frames. The ...
... is a memory metal segment under the Charmant ... better fitting frame that's comfortable yet durable. Small ... or break won't faze CFX because it automatically ... classic to modern to sporty and is coupled ...
... Collection is the world's most extensive ... 100% pure titanium and beta-titanium frames ... superior corrosion resistance. This coupled with ... a collection that is a step ...
Medicine Products: